AOCI at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s AOCI?
- Aura Biosciences, Inc. (AURA) reported AOCI of -$207K in Q1 2026.
- How has Aura Biosciences, Inc.'s AOCI changed year-over-year?
- Aura Biosciences, Inc.'s AOCI decreased by 297.1% year-over-year, from $105K to -$207K.
- What is the long-term trend for Aura Biosciences, Inc.'s AOCI?
- Over 3 years (2022 to 2025), Aura Biosciences, Inc.'s AOCI has grown at a 12.3% compound annual growth rate (CAGR), from -$72K to -$102K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.